Blog
Mastering GMP Manufacturing of Gene Therapy Nanoparticles
๐ Navigating GMP Manufacturing of mRNA-Lipid Nanoparticles explores challenges, technologies, and regulations in gene therapy production. ๐ฌ๐ก๐
Breakthrough Partnership: GSK and Elegen Revolutionize DNA Medicines
๐ฌ GSK teams up with Elegen Bio to develop DNA-based medicines and vaccines, revolutionizing the field of biotechnology. ๐๐
Patient Advocate Slams FDA’s CAR-T Warning Labels: Is Patient Safety at Risk?
๐บ Patient advocate slams FDA decision on CAR-T warning labels, arguing it undermines patient knowledge and autonomy. ๐บ Warning labels may deter patients from seeking life-saving CAR-T therapies. ๐บ Advocates prioritize informed consent and patient education over warnings. ๐บ Critics fear labels could cause unnecessary fear and anxiety. ๐บ FDA decision raises concerns on patient safety vs. access to innovative therapies.
World’s First CRISPR Cell Therapy Approved for Sickle Cell – Solvias to Perform Testing
๐ฐ Solvias will perform release testing on CASGEVY, the world's first CRISPRCas9 genome-edited cell therapy. ๐งช๐๐ฌโ ๐
Dutch Biotech Firm Raises โฌ75m to Fight Diseases
๐ฐ Dutch biotech firm Forbion leads โฌ75m funding for Calluna Pharma, a newly formed company targeting inflammatory and fibrotic diseases.
Catalent’s Game-Changing CAR-T Platform Revolutionizes Immunocellular Therapy
๐ Catalent launches a plug-and-play CAR-T platform ๐ ๏ธ designed to streamline development and manufacturing of immunocellular therapies. ๐๐ฌ๐ผ
Revolutionary Tech Boosts Quality & Efficiency in AAV Manufacturing
An Essential PAT Technology for Downstream Processing in AAV Manufacturing explores how PAT enhances AAV production quality and efficiency. ๐ฐ๐๐ฌโ๏ธ๐
Roche Abandons AC Immune Collaboration Returns Drugs
๐ฐ Roche's US subsidiary, Genentech, ๐ข jumps ship on AC Immune after disappointing study results. ๐งช๐ Crenezumab and Semorinemab returned. ๐ช AC Immune remains focused on other therapies. ๐ฐ๐
EU Decision on Genomic Techniques: Last Chance Before Elections
๐ On January 22, 2024, EU Parliament calls for patent ban on NGT-1 breeds. Tomorrow, ENVI Committee gives input on draft law. Germany, Belgium, & Bulgaria abstain. Poland supports product labeling. Decision crucial before elections & new European Commission.
Gilead Ditches Oceanside Boosts Biologics in Foster City!
๐ซ Gilead cancels Oceanside expansion plans ๐, shifts biologics production to Foster City ๐๏ธ. Read more about the move! ๐ฅ
